Interleukin Genetics Stock Price, News & Analysis (OTCMKTS:ILIU)

$0.0045 0.00 (0.00 %)
(As of 01/19/2018 12:51 PM ET)
Previous Close$0.00
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average Volume99,960 shs
Market Capitalization$1.03 million
P/E Ratio-0.11
Dividend YieldN/A
Beta2.12

About Interleukin Genetics (OTCMKTS:ILIU)

Interleukin Genetics, Inc. develops and markets genetic tests for chronic diseases and health-related conditions. The Company operates through the genetic test business segment. The Company's products include PerioPredict genetic test and Inherent Health line of genetic tests. PerioPredict is a genetic risk test that analyzes genetic variations associated with inflammation and identifies individuals with a life-long predisposition to over-produce inflammation. PerioPredict identifies specific polymorphisms (genetic variations) in genes that regulate the production of interleukin-1 cytokines. PerioPredict identifies adults at increased risk for severe periodontal disease. The Company markets additional genetic tests through its Inherent Heath brand. Its additional genetic tests include weight management genetic test, bone health genetic test, heart health genetic test, nutritional needs genetic test and wellness select genetic test.

Receive ILIU News and Ratings via Email

Sign-up to receive the latest news and ratings for ILIU and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:ILIU
CUSIPN/A
Phone+1-781-3980700

Debt

Debt-to-Equity Ratio-0.16%
Current Ratio0.23%
Quick Ratio0.22%

Price-To-Earnings

Trailing P/E Ratio-0.1125
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.51 million
Price / Sales0.41
Cash FlowN/A
Price / CashN/A
Book Value($0.01) per share
Price / Book-0.45

Profitability

Trailing EPS($0.04)
Net Income$-7,410,000.00
Net Margins-1,287.78%
Return on EquityN/A
Return on Assets-353.70%

Miscellaneous

EmployeesN/A
Outstanding Shares229,470,000

Interleukin Genetics (OTCMKTS:ILIU) Frequently Asked Questions

What is Interleukin Genetics' stock symbol?

Interleukin Genetics trades on the OTCMKTS under the ticker symbol "ILIU."

How were Interleukin Genetics' earnings last quarter?

Interleukin Genetics, Inc (OTCMKTS:ILIU) announced its quarterly earnings data on Friday, May, 12th. The company reported ($0.01) EPS for the quarter. The business earned $0.20 million during the quarter. View Interleukin Genetics' Earnings History.

Who are some of Interleukin Genetics' key competitors?

Who are Interleukin Genetics' key executives?

Interleukin Genetics' management team includes the folowing people:

  • Barry Kallander, President, Treasurer, Secretary, Director
  • Stephan Toutain, Chief Commercial Officer (Age 50)
  • Dayton C. Misfeldt, Independent Director (Age 43)

How do I buy Interleukin Genetics stock?

Shares of Interleukin Genetics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Interleukin Genetics' stock price today?

One share of Interleukin Genetics stock can currently be purchased for approximately $0.00.

How big of a company is Interleukin Genetics?

Interleukin Genetics has a market capitalization of $1.03 million and generates $2.51 million in revenue each year. The company earns $-7,410,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.

How can I contact Interleukin Genetics?

Interleukin Genetics' mailing address is 135 Beaver St, WALTHAM, MA 02452-8412, United States. The company can be reached via phone at +1-781-3980700 or via email at [email protected]


MarketBeat Community Rating for Interleukin Genetics (ILIU)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  20 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  37
MarketBeat's community ratings are surveys of what our community members think about Interleukin Genetics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Interleukin Genetics (OTCMKTS:ILIU) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Interleukin Genetics (OTCMKTS:ILIU) Earnings History and Estimates Chart

Earnings by Quarter for Interleukin Genetics (OTCMKTS:ILIU)

Interleukin Genetics (OTCMKTS ILIU) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/12/2017Q1 2017($0.01)$0.20 millionViewN/AView Earnings Details
4/18/2017Q4 2016($0.01)ViewN/AView Earnings Details
11/15/2016Q3 2016($0.01)$0.73 millionViewN/AView Earnings Details
8/15/2016Q2($0.01)($0.01)$0.25 million$0.59 millionViewListenView Earnings Details
5/12/2016Q1($0.01)($0.01)$0.27 million$0.96 millionViewListenView Earnings Details
3/17/2016Q4($0.01)($0.01)$0.31 million$0.37 millionViewListenView Earnings Details
11/12/2015Q3($0.01)($0.01)$0.36 million$0.30 millionViewN/AView Earnings Details
8/14/2015($0.01)($0.01)ViewN/AView Earnings Details
8/14/2015Q2($0.01)($0.01)$0.37 million$0.38 millionViewListenView Earnings Details
5/15/2015Q1 2015($0.01)ViewN/AView Earnings Details
3/20/2015Q4 2014($0.01)($0.01)$0.52 million$0.32 millionViewN/AView Earnings Details
11/14/2014Q3 2014($0.01)($0.01)$0.58 million$0.47 millionViewN/AView Earnings Details
8/13/2014Q2 2014($0.01)($0.01)$0.47 million$0.53 millionViewN/AView Earnings Details
5/14/2014Q1 2014($0.01)($0.01)ViewN/AView Earnings Details
3/20/2014Q4 13($0.01)($0.02)$0.54 million$0.67 millionViewN/AView Earnings Details
11/14/2013Q3($0.01)($0.02)ViewListenView Earnings Details
8/14/20132Q13($0.02)ViewN/AView Earnings Details
5/14/2013Q1 2013($0.03)($0.03)ViewN/AView Earnings Details
3/28/2013Q4 12($0.03)ViewN/AView Earnings Details
11/14/2012Q3 2012($0.04)($0.03)ViewN/AView Earnings Details
8/14/2012Q2 2012($0.03)($0.03)ViewN/AView Earnings Details
5/10/2012Q1 2012($0.04)($0.04)ViewN/AView Earnings Details
3/29/2012Q4 2011($0.03)($0.04)ViewN/AView Earnings Details
11/10/2011Q3 2011($0.04)($0.03)ViewN/AView Earnings Details
8/12/2011Q2 2011($0.04)($0.04)ViewN/AView Earnings Details
5/12/2011Q1 2011($0.04)($0.03)ViewN/AView Earnings Details
3/21/2011Q4 2010($0.04)($0.03)ViewN/AView Earnings Details
11/11/2010Q3 2010($0.06)($0.04)ViewN/AView Earnings Details
8/12/2010Q2 2010($0.06)($0.05)ViewN/AView Earnings Details
5/13/2010Q1 2010($0.05)($0.06)ViewN/AView Earnings Details
11/12/2009Q3 2009($0.08)ViewN/AView Earnings Details
8/13/2009Q2 2009($0.07)ViewN/AView Earnings Details
5/14/2009Q1 2009($0.08)ViewN/AView Earnings Details
3/9/2009Q4 2008($0.04)($0.05)ViewN/AView Earnings Details
11/13/2008Q3 2008($0.05)($0.05)ViewN/AView Earnings Details
8/13/2008Q2 2008($0.06)($0.05)ViewN/AView Earnings Details
5/14/2008Q1 2008($0.05)($0.06)ViewN/AView Earnings Details
3/27/2008Q4 2007($0.05)($0.05)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Interleukin Genetics (OTCMKTS:ILIU) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Interleukin Genetics (OTCMKTS:ILIU)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Interleukin Genetics (OTCMKTS ILIU) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 54.40%
Institutional Ownership Percentage: 0.53%
Insider Trades by Quarter for Interleukin Genetics (OTCMKTS:ILIU)

Interleukin Genetics (OTCMKTS ILIU) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/29/2016Bay City Capital Fund V, L.P.Major ShareholderBuy30,181,086$0.10$3,018,108.60View SEC Filing  
7/29/2016Kenneth S. KornmanInsiderBuy25,150$0.10$2,515.00View SEC Filing  
7/29/2016Stephen J DipalmaCFOBuy100,603$0.10$10,060.30349,855View SEC Filing  
12/23/2014Bay City Capital LlcMajor ShareholderBuy26,491,952$0.10$2,649,195.20View SEC Filing  
12/23/2014Stephen J DipalmaCFOBuy249,252$0.10$24,925.20View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Interleukin Genetics (OTCMKTS ILIU) News Headlines

Source:

SEC Filings

Interleukin Genetics (OTCMKTS:ILIU) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Interleukin Genetics (OTCMKTS:ILIU) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Interleukin Genetics (OTCMKTS ILIU) Stock Chart for Friday, January, 19, 2018

Loading chart…

This page was last updated on 1/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.